Patent · US Active

Method of treating inherited severe neutropenia

US8283344B2 · kind B2 · utility

1Cited by

2References

9Claims

0Family size

Assignees

MERCK & CO., INC. · US
University of Washington · US

Inventors

David C. Dale · Seattle, US
Paul E. Finke · Milltown, US
Richard A. Mumford · Red Bank, US
Andranik Andrew Aprikyan · Kenmore, US

Key dates

Filing date	Sep 5, 2008
Grant date	Oct 9, 2012
Priority date	—
Expiry date	Feb 26, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is directed to a method of treating severe neutropenia, and in particular, cyclic neutropenia (CN) or severe congenital neutropenia (SCN), in a patient in need of such treatment comprising: administering a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.